Medical therapy for benign prostatic hyperplasia.

Suppr

超能文献

作者信息

Lepor H

机构信息

Department of Urology, New York University Medical Center, New York.

出版信息

Urology. 1993 Nov;42(5):483-501. doi: 10.1016/0090-4295(93)90258-c.

DOI:10.1016/0090-4295(93)90258-c

PMID:7694413

Abstract

摘要

相似文献

Medical therapy for benign prostatic hyperplasia.

Urology. 1993 Nov;42(5):483-501. doi: 10.1016/0090-4295(93)90258-c.

The role of alpha 1-blockade in benign prostatic hyperplasia.α1受体阻滞剂在良性前列腺增生中的作用。

J Clin Pharmacol. 1993 Sep;33(9):891-5.

[Alpha blockers in the treatment of benign hyperplasia of the prostate].

Rev Clin Esp. 1997 May;197(5):358-62.

Re: A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia.回复：一项关于抗雄激素药物康士得作为良性前列腺增生患者治疗方法的前瞻性、安慰剂对照研究。

J Urol. 1994 May;151(5):1355-6. doi: 10.1016/s0022-5347(17)35254-0.

The role of combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.联合治疗对良性前列腺增生继发下尿路症状的作用。

Curr Urol Rep. 2003 Aug;4(4):276-81. doi: 10.1007/s11934-003-0084-1.

Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem.α受体阻滞剂治疗良性前列腺增生症：生理基础及问题综述

Eur Urol. 1984;10(5):306-10. doi: 10.1159/000463816.

[The use of terazosin hydrochloride (Hytrin) in the treatment of patients with benign prostatic hyperplasia].

Urol Nefrol (Mosk). 1997 Sep-Oct(5):50-3.

Therapeutic controversies: clinical treatment of benign prostatic hyperplasia.治疗争议：良性前列腺增生的临床治疗

J Clin Endocrinol Metab. 1995 Mar;80(3):745-7. doi: 10.1210/jcem.80.3.7533770.

[Pharmacologic treatment of benign prostatic hyperplasia].[良性前列腺增生的药物治疗]

Orv Hetil. 2003 Sep 14;144(37):1809-14.

Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonists in the prostate.良性前列腺增生的医学管理：一种比较α-1肾上腺素能拮抗剂在前列腺体内疗效的犬类模型。

J Urol. 1993 Feb;149(2):395-9. doi: 10.1016/s0022-5347(17)36102-5.

引用本文的文献

Comparative study of tamsulosin versus tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms. A prospective randomized study.坦索罗辛与他达拉非治疗良性前列腺增生伴下尿路症状患者的比较研究。一项前瞻性随机研究。

Urol Ann. 2022 Jul-Sep;14(3):236-240. doi: 10.4103/ua.ua_6_21. Epub 2022 Apr 14.

Mechanisms of Lower Urinary Tract Symptoms in Pelvic Ischemia.盆腔缺血时下尿路症状的机制

J Biochem Pharmacol Res. 2013;1(1):64-74.

Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia.坦索罗辛0.4毫克对有症状的良性前列腺增生患者的疗效和耐受性

Korean J Urol. 2011 Jul;52(7):479-84. doi: 10.4111/kju.2011.52.7.479. Epub 2011 Jul 24.

Benign prostatic hyperplasia: An overview of existing treatment.良性前列腺增生：现有治疗方法概述。

Indian J Pharmacol. 2011 Feb;43(1):6-12. doi: 10.4103/0253-7613.75657.

Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia.良性前列腺增生的病理生理学、流行病学及自然史

Rev Urol. 2004;6 Suppl 9(Suppl 9):S3-S10.

Urethral pressure profile and hemodynamic effects of phenoxybenzamine and prazosin in non-sedated male beagle dogs.苯苄胺和哌唑嗪对未镇静雄性比格犬尿道压力分布及血流动力学的影响

Can J Vet Res. 2003 Jan;67(1):30-8.

Alfuzosin: a review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia.阿夫唑嗪：每日一次长效制剂治疗良性前列腺增生的疗效综述

Drugs. 2002;62(4):633-53. doi: 10.2165/00003495-200262040-00009.

Effects of doxazosin in men with benign prostatic hyperplasia: urodynamic assessment.多沙唑嗪对良性前列腺增生男性患者的影响：尿动力学评估

Int Urol Nephrol. 1999;31(4):471-9. doi: 10.1023/a:1007111211130.

Underdetection of clinical benign prostatic hyperplasia in a general medical practice.

J Gen Intern Med. 1996 Sep;11(9):513-8. doi: 10.1007/BF02599597.

ACP Broadsheet No 146: August 1995. Macroscopic examination of prostatic specimens.《内科学年鉴》简报第146期：1995年8月。前列腺标本的宏观检查。

J Clin Pathol. 1995 Aug;48(8):693-700. doi: 10.1136/jcp.48.8.693.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验